Physician profile
Thomas Scott Eagan
NPI 1578713673
$10,742.19
in general payments reported to CMS, 2019-2025
12 companies · $5,223 in 2025
The $5,223 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.66 · 2020: $11.17 · 2021: $134 · 2022: $64.11 · 2023: $1,079 · 2024: $4,189 · 2025: $5,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,085 · Travel and Lodging: $2,374 · Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,085.03 |
| Travel and Lodging | $2,374.04 |
| Food and Beverage | $1,031.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,840.17 | 2023-2025 | Da Vinci Surgical System |
| Abbvie INC. | $319.17 | 2019-2024 | Liletta, Orilissa, Lo Loestrin Fe |
| Coloplast Corp | $218.83 | 2021-2025 | |
| Hologic Sales and Service, LLC | $89.84 | 2021-2025 | Fluent Fluid Management System, Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $66.72 | 2020-2024 | Veozah |
| Biogen, INC. | $56.66 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $51.75 | 2024-2025 | |
| Coopersurgical, INC. | $29.17 | 2019-2021 | |
| Organon LLC | $20.76 | 2022 | |
| Axonics, INC. | $19.66 | 2024 | Bulkamid |
| Therapeuticsmd, INC. | $14.93 | 2019 | |
| Agile Therapeutics, INC. | $14.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Eagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.